Identification of 13 novel USH2A mutations in Chinese retinitis pigmentosa and Usher syndrome patients by targeted next-generation sequencing

• Published in: Bioscience reports Vol. 40; no. 1
• Main Authors: Qu, Ling-hui, Jin, Xin, Long, Yan-ling, Ren, Jia-yun, Weng, Chuang-huang, Xu, Hai-wei, Liu, Yong, Meng, Xiao-hong, Li, Shi-ying, Yin, Zheng-qin
• Format: Journal Article
• Language: English
• Published: England Portland Press Ltd 31.01.2020
• Subjects: Adult; Asian Continental Ancestry Group - genetics; Case-Control Studies; China; Diagnostics & Biomarkers; DNA Mutational Analysis; Extracellular Matrix Proteins - genetics; Female; Genetic Association Studies; Genetic Predisposition to Disease; Heredity; High-Throughput Nucleotide Sequencing; Humans; Male; Middle Aged; Molecular Bases of Health & Disease; Mutation; Pedigree; Phenotype; Retinitis Pigmentosa - diagnosis; Retinitis Pigmentosa - ethnology; Retinitis Pigmentosa - genetics; Usher Syndromes - diagnosis; Usher Syndromes - ethnology; Usher Syndromes - genetics; Young Adult; China; USH2A gene; Non-syndromic retinitis pigmentosa; Usher syndrome
• ISSN: 0144-8463; 1573-4935; 1573-4935
• DOI: 10.1042/BSR20193536

Background: The USH2A gene encodes usherin, a basement membrane protein that is involved in the development and homeostasis of the inner ear and retina. Mutations in USH2A are linked to Usher syndrome type II (USH II) and non-syndromic retinitis pigmentosa (RP). Molecular diagnosis can provide insight into the pathogenesis of these diseases, facilitate clinical diagnosis, and identify individuals who can most benefit from gene or cell replacement therapy. Here, we report 21 pathogenic mutations in the USH2A gene identified in 11 Chinese families by using the targeted next-generation sequencing (NGS) technology. Methods: In all, 11 unrelated Chinese families were enrolled, and NGS was performed to identify mutations in the USH2A gene. Variant analysis, Sanger validation, and segregation tests were utilized to validate the disease-causing mutations in these families. Results: We identified 21 pathogenic mutations, of which 13, including 5 associated with non-syndromic RP and 8 with USH II, have not been previously reported. The novel variants segregated with disease phenotype in the affected families and were absent from the control subjects. In general, visual impairment and retinopathy were consistent between the USH II and non-syndromic RP patients with USH2A mutations. Conclusions: These findings provide a basis for investigating genotype–phenotype relationships in Chinese USH II and RP patients and for clarifying the pathophysiology and molecular mechanisms of the diseases associated with USH2A mutations.